Evidence from gene-expression profiling of the inhibition by niacinamide of both innate and adaptive immune response processes and pathways associated with skin photoaging - 13/02/13
Michael K. Robinson, PhD, The Procter and Gamble Company, Cincinnati, OH, United States; Jay P. Tiesman, PhD, The Procter and Gamble Company, Cincinnati, OH, United States; Kenton D. Juhlin, PhD, The Procter and Gamble Company, Cincinnati, OH, United States; Kevin J. Mills, PhD, The Procter and Gamble Company, Cincinnati, OH, United States; Robert L. Binder, PhD, The Procter and Gamble Company, Cincinnati, OH, United States; Rosemarie Osborne, PhD, The Procter and Gamble Company, Cincinnati, OH, United States; Scott M. Hartman, The Procter and Gamble Company, Cincinnati, OH, United States
Le texte complet de cet article est disponible en PDF. 100% funded by The Procter and Gamble Company. |
Vol 68 - N° 4S1
P. AB36 - avril 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?